Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials-Reference-Cited by-同舟云学术

Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials

Published:2007-06 Issue:2 Volume:13 Page:137-177
ISSN:1080-563X
Container-title:CNS Drug Reviews
language:en
Short-container-title:CNS Drug Reviews

Author:

Greenberg William M.¹,Citrome Leslie¹

Affiliation:

1. Department of Psychiatry, New York University School of Medicine, New York, NY, and Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA

Publisher

Wiley

Subject

Pharmacology,Neuropsychology and Physiological Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1527-3458.2007.00008.x

Reference86 articles.

1. Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

2. Antipsychotic‐induced weight gain: A comprehensive research synthesis;Allison DB;Am J Psychiatry,1999

3. Consensus Statement: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes

4. Tardive dyskinesia in 2 patients treated with ziprasidone;Ananth J;J Psychiatry Neurosci,2004

5. A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160???mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs and Their Mode of Action: A Review on Sulfur-Containing Heterocyclic Compounds;Polycyclic Aromatic Compounds;2024-08-27

2. Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms;Journal of Intensive Care Medicine;2023-12-21

3. Synthesis of Oxindoles via SmI2-Promoted Reduction of 2-Nitrophenylacetic Acids;Synthesis;2023-09-13

4. Pharmacotherapy and Emerging Treatment Strategies for Schizophrenia;Cognizance of Schizophrenia:: A Profound Insight into the Psyche;2023

5. Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms;Pharmacological Reports;2022-12-16